U.S. Oil and Gas Stock News

Wondering whether Travere Therapeutics at around US$44.12 is still offering value or if the easy gains are already behind it? This article unpacks what the current price really implies. The stock has shown strong share price moves, with returns of 8.9% over 7 days, 40.4% over 30 days, 11.6% year to date, 108.6% over 1 year, 162.6% over 3 years and 120.5% over 5 years. This naturally raises questions about both upside potential and risk. Recent headlines around Travere Therapeutics have...

Clearway Energy, Inc. has already converted all of its Class A common stock into Class C common stock as of May 1, 2026, with Class A trading suspended and Class C now trading on the New York Stock Exchange. This simplification of the public share structure, alongside Clearway’s simultaneous removal from numerous major Russell and S&P indexes, reshapes how index funds and active investors may gain exposure to the company. We’ll now examine how Clearway’s shift to a single Class C share...

Synchrony and Lowe's Companies have expanded their partnership with the launch of the MyLowe's Pro Rewards American Express Card. The new co branded card extends purchasing power and rewards for professional customers beyond Lowe's stores to any location where American Express is accepted. The offering targets small to medium business customers within Lowe's Pro segment, with a focus on broader rewards and financing flexibility. Lowe's Companies, NYSE:LOW, is trading at $233.33, with the...

Sable Offshore Corp. recently resumed oil transportation through key pipeline segments and expanded drilling activity after federal intervention resolved prior regulatory hurdles that had stalled production in 2025. Alongside this operational restart, the company’s executives converted large blocks of restricted stock units and sold shares mainly to cover tax obligations, underscoring substantial ongoing insider equity exposure. We’ll now examine how the resumption of oil production...

Sprouts Farmers Market is opening its first New York store as part of an accelerated nationwide rollout. The company plans more than 40 new locations in 2026, expanding its footprint beyond existing core regions. Management is rolling out targeted price adjustments, loyalty program efforts, and supply chain work to support long term growth after recent comparable sales declines. Sprouts Farmers Market, NasdaqGS:SFM, is pushing into new territory with its New York entry while ramping up...

Carnival Corporation & (NYSE:CCL) has been hit by a significant ransomware attack linked to the hacking group ShinyHunters. The incident reportedly involves more than 8,700,000 records containing sensitive personal data. Multiple class action lawsuits have been filed, alleging weak cybersecurity controls and slow notification to affected individuals. The breach is drawing fresh attention to the company’s data security practices and operational risk. Carnival Corporation & enters this data...

Event overview and recent share performance Charles River Laboratories International (CRL) has drawn investor attention after a period of weaker share performance, with the stock showing a 0.7% decline over the past day and a 2.4% decline over the past week. Those short term moves sit alongside a 5.2% decline over the past month and a 21.2% decline over the past 3 months. The shares are still up 40.0% over the past year and down 51.6% over 5 years. See our latest analysis for Charles River...

Bristol-Myers Squibb (BMY) opened 2026 with Q1 revenue of US$11.5b, basic EPS of US$1.31 and net income of US$2.7b, setting the tone for how investors will judge its recent profitability. The company has seen quarterly revenue move from US$11.2b and basic EPS of US$1.21 in Q1 2025 to US$11.5b and US$1.31 in Q1 2026. Trailing twelve month EPS reached US$3.57, giving a clearer read on earnings power over the last year. With trailing net profit margin at 15% and recent earnings growth of 34.2%...

Eastman Chemical Q1 2026 earnings: headline numbers in focus Eastman Chemical (EMN) has opened 2026 with Q1 revenue of US$2.2b and basic EPS of US$0.94, setting the stage for how investors assess the latest move in profitability. Over recent quarters the company has seen revenue move between US$2.0b and US$2.3b, with basic EPS ranging from US$0.41 to US$2.85, while trailing twelve month EPS sits at US$3.49 on revenue of US$8.6b. With the stock at US$77.53 and trailing net margin at 4.6%...

Tesla has started mass production of its long delayed Semi electric truck. The company has begun customer deliveries, moving the Semi from pilot runs to volume manufacturing in Nevada. This marks a major push beyond consumer vehicles into commercial freight and logistics. Tesla, NasdaqGS:TSLA, is extending its reach beyond passenger cars with the Semi entering full scale production. The move comes as the stock trades around $390.82, with a 36.1% return over the past year and a 129.8% return...

Why Phibro Animal Health stock is on investors’ radar Recent trading in Phibro Animal Health (PAHC) has drawn attention, with the share price at $54.89 and total return data over the past month and past 3 months prompting closer scrutiny of the business fundamentals. See our latest analysis for Phibro Animal Health. That recent one day share price return of 3.22% sits on top of a 36.71% 90 day share price return and a very large 1 year total shareholder return, which suggests momentum has...

Media spotlight puts Talen Energy (TLN) in focus Interest in Talen Energy (TLN) has picked up after Jim Cramer highlighted the stock on Mad Money, calling it a power infrastructure play with limited yield appeal, while advising a viewer to hold rather than sell. See our latest analysis for Talen Energy. Despite the recent TV spotlight, Talen Energy’s share price return over the past month is 13.44%. The year-to-date share price return is 6.19% lower, and the 1 year total shareholder return is...

In late April 2026, semiconductor manufacturer IPG Photonics was caught in a broad sector selloff as concerns over future artificial intelligence spending and rising U.S.-China technology tensions weighed on investor sentiment and raised fears of supply chain disruption. The key takeaway is that IPG Photonics’ recent volatility appears tied more to macro and industry-wide semiconductor worries than to any company-specific operational change or new information about its core laser...

Recursion Pharmaceuticals recently confirmed it will report first-quarter 2026 results and business updates on May 6, 2026, with a publicly accessible earnings call allowing questions from investors and the broader community. At the same time, the company flagged leadership changes, including Chris Gibson, Ph.D., stepping down from the Board in June 2026 while remaining an advisor, underscoring an emphasis on continuity and its AI-driven drug discovery platform. We’ll examine how the...

T. Rowe Price Group (TROW) opened 2026 with Q1 revenue of US$1.9 billion and basic EPS of US$2.23, alongside trailing twelve month revenue of US$7.4 billion and EPS of US$9.34 that sit against modest 1.9% annual revenue growth and a 27.6% net profit margin over the past year. Over recent quarters, revenue has ranged from US$1.7 billion to US$1.9 billion, while quarterly EPS has moved between roughly US$1.93 and US$2.88. This provides a consistent picture of earnings power, even as the five...

Why EnerSys Is On Investors’ Radar Today EnerSys (ENS) has caught attention after a strong run over the past year, prompting investors to reassess what the current share price might already reflect about its business mix and fundamentals. See our latest analysis for EnerSys. Recent trading has been dominated by strong momentum, with a 19.4% 1 month share price return and 40.9% year to date share price return contributing to a 136.0% 1 year total shareholder return. This points to shifting...

Wondering if Cardinal Health at US$195.24 is still offering value after a strong multi year run? This article breaks down what the current price might be saying about the stock. The share price has eased recently, with a 2.3% decline over 7 days, a 7.9% decline over 30 days and a 5.1% decline year to date, even though the 1 year return stands at 32.0% and the 5 year return is 276.7%. Recent coverage around Cardinal Health has focused on its position in healthcare distribution and ongoing...

What recent returns suggest about C.H. Robinson Worldwide C.H. Robinson Worldwide (CHRW) has delivered mixed share price moves recently, with a 1 day return of 2.5% and a 7 day decline of 3.1%, while the past month shows a 5.2% gain. Over the past 3 months the stock shows a 9.1% decline, yet its 1 year total return of 98.9% and 5 year total return of 100.2% present a very different longer term picture for investors to weigh. See our latest analysis for C.H. Robinson Worldwide. At a share...

In April 2026, Kyndryl and Google Cloud expanded Kyndryl’s Distributed Cloud services to help enterprises modernize applications and deploy AI across hybrid, multicloud, and edge environments while addressing data sovereignty, regulatory, and performance needs. This move deepens Kyndryl’s role as an end-to-end cloud and IT services provider, positioning its experts at the center of Kubernetes-based modernization and AI workload deployment across complex infrastructures. Next, we’ll examine...

Investors may be wondering whether Take-Two Interactive Software, at around US$216 a share, still offers value or if most of the opportunity is already priced in. The stock has returned 2.5% over the last week and 9.0% over the past month. The year-to-date return is a 14.1% decline and the 1-year return is a 1.6% decline, set against a 73.5% return over 3 years and 27.0% over 5 years. Recent attention on Take-Two has centered on its position as a major publisher in interactive entertainment...

Smokey Bones, the barbecue chain originally founded by Darden Restaurants, has been fully closed after a 27 year run. The shutdown ends a long standing brand legacy that traces back to Darden’s earlier expansion in American casual dining. Although Darden no longer owns Smokey Bones, the closure adds context for investors tracking NYSE:DRI and the broader barbecue and casual dining space. Darden Restaurants, trading as NYSE:DRI, is coming off a mixed share performance backdrop, with the...

If you are wondering whether Kimco Realty's current share price lines up with its underlying value, this article walks through the key numbers so you can judge that for yourself. Over recent periods the stock has seen mixed returns, with a 1.3% decline over the last 7 days, a 4.1% gain over 30 days, 16.6% year to date, 16.0% over 1 year, 43.7% over 3 years and 35.3% over 5 years. Recent coverage of Kimco Realty has focused on its role as a large retail REIT and how investors are weighing...

Neurocrine Biosciences (NasdaqGS:NBIX) reported new two‑year Phase 3 data from its CAHtalyst Pediatric and Adult trials of CRENESSITY in classic congenital adrenal hyperplasia. The peer‑reviewed results cover both children and adults and highlight durable efficacy alongside physiologic glucocorticoid dosing. Data show sustained reductions in harmful steroid exposure and clinical improvements, including better body mass index and insulin resistance in pediatric patients. These findings...

In the lead-up to its 5 May 2026 earnings release, California Resources Corporation has been projected to post year-over-year declines in earnings and modestly lower revenues, even as Vanguard Portfolio Management disclosed a passive 5.94% ownership stake as of 31 March 2026. This combination of cautious profit expectations and increased institutional ownership highlights how investors are repositioning around California Resources’ evolving earnings profile and carbon-focused business...